EHOC

Registration & Accommodation

Programs




Leukemia Research

Committees

General Information

Hematology Program 20 October 2018

MEET THE EXPERT SESSION & ORAL PRESENTATIONS - ROOM 1 (MERCURY HALL) - Panayiotis Panayiotidis (CLL) Chairs: Panayiotis Panayiotidis, Salih Aksu
OP-38 SANEM FISTIK INTERLEUKIN-6 AND INTERLEUKIN-10 GENE POLYMORPHISMS AT CHRONIC LYMPHOID LEUKEMIA PATIENTS
OP-11 AYTAN SHIRINOVA ORGANIZATION OF THERAPY OF CHRONIC MYELOID LEUKEMIA (CML) IN AZERBAIJAN: ANALYSIS AND PROSPECTS
OP-12 SHERBET ZHUSUPOVA REGISTER AND EPIDEMIOLOGICAL FEATURES OF CHRONIC MYELOIDE LEUKEMIA (CML) IN KYRGYZSTAN
OP-09 KORAY GÜL SINGLE CENTER EXPERIENCE: LONG TERM TREATMENT RESULTS IN THROMBOTIC THROMBOCYTOPENIC PURPURA
MEET THE EXPERT SESSION & ORAL PRESENTATIONS - ROOM 2 (JUPITER HALL) - Massimo Federico (NHL) Chairs: Massimo Federico, Cengiz Ceylan
OP-25 FATOŞ DİLAN ATİLLA CLINICAL ASPECTS OF PRIMARY THYROID LYMPHOMA
OP-24 HATİCE DEMET KİPER ÜNAL ANALYSIS OF CLINICAL AND HISTOPATHOLOGICAL PROGNOSTIC FACTORS IN GASTROINTESTINAL SYSTEM LYMPHOMAS
OP-15 CEM KURT FLOW CYTOMETRY ANALYSIS OF THE ACUTE EBV INFECTON AMONG PATIENTS WITH HAEMATOLOGICAL DISORDERS
OP-21 ATAKAN TURGUTKAYA CAN KI-67 EXPRESSION DETERMINE PROGNOSIS BETTER AT DOUBLE/TRIPPLE EXPRESSOR LYMPHOMA?
MEET THE EXPERT SESSION & ORAL PRESENTATIONS - ROOM 3 (SATURN HALL) - Giuseppe Saglio (AML) Chairs: Giuseppe Saglio , Mehmet Sönmez
OP-32 ŞULE ÜNAL HEMATOLOGICAL MALIGNANCIES AND OUTCOMES IN PATIENTS WITH FANCONI ANEMIA: A SINGLE CENTER EXPERIENCE
OP-36 ZEYNEP KARAKAŞ THE RELATIONSHIP BETWEEN ENDOGEN ANTIOXIDANTS AND TOTAL OXIDANT AND ANTIOXIDANT CAPACITY IN PATIENTS WITH BETA THALASSEMIA
OP-33 ESİN KARAKILIÇ ÖZTURHAN ETIOLOGICAL CLASSIFICATION OF NEUTROPENIA DETECTED IN CHILDREN BETWEEN 3 MONTHS AND 18 YEARS OF AGE: A CROSS-SECTIONAL STUDY IN A TERTIARY CENTER
OP-04 HÜSEYİN DERYA DİNÇYÜREK FIRST USE OF PLASMAPHERESIS IN THE TREATMENT OF T CELL ENGAGING THERAPIES RELATED ADVERSE EFFECTS